The (±)-tetrahydro-3-furylmethyl moiety, which is a characteristic part of the novel neonicotinoid dinotefuran, was found by research in which acetylcholine was selected as the lead compound. SAR (structure-activity relationships) for the tetrahydrofuran part indicated that the non-substituted moiety showed the highest level of activity, 4- and 5-substituted moieties showed intermediate levels, and 2- and 3-substituted moieties lost the activity. Conformational analysis of these compounds indicated that the substituents changed little the hypothetical active conformation of dinotefuran. Computational analysis proved that dinotefuran, a methoxypropyl compound and other neonicotinoids well overlapped, and dinotefuran adopts the active conformation more easily than the methoxypropyl compound.
No takes yet. Share an insight, caveat, or question.
Wakita et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: